Hepatitis B virus X antigen promotes transforming growth factor- β1 (TGF- β1) activity by up-regulation of TGF-β1 and down-regulation by α2-macroglobulin

Journal of General Virology

Volumn 85, Issue 2, 2004, Pages 275-282

  Pan, Jingbo ^a   Clayton, Marcy ^a   Feitelson, Mark A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; HEPATITIS B ANTIGEN; HEPATITIS B X ANTIGEN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL LINE; CELL STRAIN HEPG2; CONTROLLED STUDY; CULTURE MEDIUM; DNA DETERMINATION; DNA SYNTHESIS; DOWN REGULATION; EXTRACELLULAR SPACE; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL CARCINOMA; LUNG ALVEOLUS CELL; MINK; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ISOLATION; SENSITIVITY ANALYSIS; UPREGULATION; WESTERN BLOTTING;

ALPHA-MACROGLOBULINS; CARCINOMA, HEPATOCELLULAR; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; LIVER NEOPLASMS; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

HEPATITIS B VIRUS;

EID: 1342332032     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.19650-0     Document Type: Article

References (58)

1. Akhurst, R. J. (2002). TGF-β antagonists: why suppress a tumor suppressor? J Clin Invest 109, 1533-1536.
2. Armendariz-Borunda, J., Seyer, J. M., Kang, A. H. & Raghow, R. (1990). Regulation of TGF-β gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 4, 215-221.
3. Bachem, M. G., Riess, U., Melchior, R., Sell, K. M. & Gressner, A. M. (1989). Transforming growth factor (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells. FEBS Lett 257, 134-137.
4. Beg, A. A. & Baltimore, D. (1996). An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274, 782-784.
5. Beg, A., Sha, W., Bronson, R., Ghosh, S. & Baltimore, D. (1995). Embryonic lethality and liver regeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170.
6. Benn, J. & Schneider, R. J. (1994). Hepatitis B virus HBX protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A 91, 10350-10354.
7. Benson, D. A., Boguski, M. S., Lipman, D. J. & Ostell, J. (1997). GenBank. Nucleic Acids Res 25, 1-6.
8. Bode, J. G., Fischer, R., Haussinger, D., Graeve, L., Heinrich, P. C. & Schaper, F. (2001). The inhibitory effect of IL-1 beta on IL-6 induced alpha 2-macroglobulin expression is due to activation of NF-kappa B. J Immunol 167, 1469-1481.
9. Borth, W. (1992). Alpha-2-macroglobulin, a multifunctional binding protein with targeting characteristics. FASEB J 6, 3345-3353.
10. Castilla, A., Prieto, J. & Fausto, N. (1991). Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 324, 933-940.
11. Cross, J. C., Wen, P. & Rutter, W. J. (1993). Transactivation by hepatitis B Virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc Natl Acad Sci U S A 90, 8078-8082.
12. Czaja, M. J., Weiner, F. R., Flanders, K. C., Giambrone, M. A., Wind, R., Biempica, L. & Zern, M. A. (1989). In vitro and in vivo association of transforming growth factor-β1 with hepatic fibrosis. J Cell Biol 108, 2477-2482.
13. Edwards, D. R., Murphy, G. & Reynolds, J. J. (1987). Transforming growth factor beta modulates the expression of metalloproteinase inhibitor. EMBO J 6, 1899-1904.
14. Factor, V. M., Kao, C. Y., Santoni-Rugiu, E., Woitach, J. T., Jensen, M. R. & Thorgeirsson, S. S. (1997). Constitutive expression of mature transforming growth factor β1 in the liver accelerates hepatocarcinogenesis in transgenic mice. Cancer Res 57, 2089-2095.
15. Feitelson, M. A. (1999). Hepatitis B virus in hepatocarcinogenesis. J Cell Physiol 181, 188-202.
16. Gonias, S. L., LaMarre, J., Crookston, K. P., Webb, D. J., Wolf, B. B., Lopes, M. B., Moses, H. L. & Hayes, M. A. (1994). α2-macroglobulin and the α2-macroglobulin receptor/LRP: a growth regulatory axis. Ann N Y Acad Sci 737, 273-290.
17. Gressner, A. M. & Bachem, M. G. (1995). Molecular mechanisms of liver fibrogenesis - a homage to the role of activated fat-storing cells. Digestion 56, 335-346.
18. Gressner, A. M., Lahme, B., Mannherz, H. G. & Polzar, B. (1997). TGF-β-mediated hepatocellular apoptosis by rat and human hepatoma cells and primary rat hepatocytes. J Hepatol 26, 1079-1092.
19. Hall, P. K. & Roberts, R. C. (1978). Physical and chemical properties of human plasma α2-macroglobulin. Biochem J 171, 27-38.
20. Henkler, F. & Koshy, R. (1996). Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis. J Viral Hepat 3, 109-121.
21. Ignotz, R. A. & Massague, J. (1986). Transforming growth factor beta stimulates the expression of fibronectin and collagen and their incorporation into extracellular matrix. J Biol Chem 261, 4337-4345.
22. Ito, N., Kawata, S., Tamura, S. & 7 other authors (1991). Elevated levels of transforming growth factor-β messenger RNA and its polypeptide in human hepatocellular carcinoma. Cancer Res 51, 4080-4083.
23. Jin, Y. M., Yun, C., Park, C., Wang, H. J. & Cho, H. (2001). Expression of hepatitis B virus X protein is closely correlated with the high periportal inflammatory activity of liver diseases. J Viral Hepat 8, 322-330.
24. Kakumu, S., Ito, Y., Takayanagi, M., Yoshioka, K., Wakita, T., Ishikawa, T., Higashi, Y. & Yang, Z. Q. (1993). Effect of recombinant human transforming growth factor β1 on immune responses in patients with chronic hepatitis B. Liver 13, 62-68.
25. Kekule, A. S., Lauer, U., Weiss, L., Luber, B. & Hofschneider, P. H. (1993). Hepatitis B virus transactivator HBx uses a tumor promoter signalling pathway. Nature 361, 742-745.
26. Koike, K., Moriya, K., Iino, S., Yotsuyanagi, H., Endo, Y., Miyamura, T. & Kurokawa, K. (1994). High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19, 810-819.
27. Kondo, T., Sakaguchi, M., Yamada, H. & Namba, M. (1998). Two dimensional gel electrophoretic analysis of the changes after immortalization of human cells: decrease of intracellular α2-macroglobulin fragment. Electrophoresis 19, 1836-1840.
28. Kortylewski, M., Feld, F., Kruger, K. D., Bahrenberg, G., Roth, R. A., Joost, H. G., Heinrich, P. C., Behrmann, I. & Barthel, A. (2003). Akt modulates STAT3-mediated gene expression through a FKHR (FOXO1a)-dependent mechanism. J Biol Chem 278, 5242-5249.
29. LaMarre, J., Wollenberg, G. K., Gonias, S. L. & Hayes, M. A. (1991). Biology of disease. Cytokine binding and clearance properties of proteinase-activated α2-macroglobulins. Lab Invest 65, 3-14.
30. Lee, Y. H. & Yun, Y. (1998). HBx protein of hepatitis B virus activates Jak1-STAT signaling. J Biol Chem 273, 25510-25515.
31. Lee, D. K., Park, S. H., Yi, Y. & 8 other authors (2001). The hepatitis B virus encoded oncoprotein pX amplifies TGF-β family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 15, 455-466.
32. Lian, Z., Pan, J., Liu, J., Zhang, S., Zhu, M., Arbuthnot, P., Kew, M. & Feitelson, M. A. (1999). The translation initiation factor, hu-Suil may be a target of hepatitis B X antigen in hepatocarcinogenesis. Oncogene 18, 1677-1687.
33. Lian, Z., Liu, J., Pan, J., Tufan, N. L. S., Zhu, M., Arbuthnot, P., Kew, M., Clayton, M. M. & Feitelson, M. A. (2001). A cellular gene up-regulated by hepatitis B virus encoded X antigen promotes hepatocellular growth and survival. Hepatology 34, 146-157.
34. McDoniels-Silvers, A. L., Nimri, C. F., Stoner, G. D., Lubet, R. A. & You, M. (2002). Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas. Clin Cancer Res 8, 1127-1138.
35. 1 in fibrotic liver disease. Hepatology 14, 269-273.
36. Natoli, G., Avantaggiati, M. L., Chirillo, P., DeMarzio, E., Collepardo, D., Falco, M., Balsano, C. & Levrero, M. (1995a). Modulation of intracellular signal transduction pathways by the hepatitis B virus transactivator pX. J Hepatol 22, 14-20.
37. Natoli, G., Ianni, A., Costanzo, A., De Petrillo, G., Ilari, I., Chirillo, P., Balsono, C. & Levrero, M. (1995b). Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene 11, 1157-1164.
38. Oshikawa, O., Tamura, S., Kawata, S. & 7 other authors (1996). The effect of hepatitis B virus X gene expression on response to growth inhibition by transforming growth factor-β1. Biochem Biophys Res Commun 222, 770-773.
39. Pan, J., Duan, L. X., Sun, B. S. & Feitelson, M. A. (2001). Hepatitis B virus X protein protects against anti-Fas-mediated apoptosis in human liver cells by inducing NF-κB. J Gen Virol 82, 171-182.
40. Paradis, V., Bieche, I., Dargere, D. & 7 other authors (2003). Molecular profiling on hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach. Determination of a molecular diagnostic index. Am J Pathol 163, 733-741.
41. Rieder, H., Armbrust, T., Meyer-zum-Buschenfelde, K. H. & Ramadori, G. (1993). Contribution of sinusoidal endothelial liver cells to liver fibrosis: expression of transforming growth factor beta 1 receptors and modulation of plasmin-generating enzymes by transforming growth factor beta 1. Hepatology 18, 937-944.
42. Sanderson, N., Factor, V., Nagy, P., Kopp, J., Kondaiah, P., Wakefield, L., Roberts, A. B., Sporn, M. B. & Thorgeirsson, S. S. (1995). Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A 95, 2572-2576.
43. Schuftan, G. G. & Bachem, M. G. (1999). α2-Macroglobulin reduces paracrine- and autocrine-stimulated matrix synthesis of cultured rat hepatic stellate cells. Eur J Clin Invest 29, 519-528.
44. Shih, W. L., Kuo, M. L., Chuang, S. E., Cheng, A. L. & Doong, S. L. (2000). Hepatitis B virus X protein inhibits transforming growth factor-β-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem 275, 25858-25864.
45. Song, B. C., Chung, Y. H., Kim, J. A. & 7 other authors (2002). Transforming growth factor-β1 as a useful serologic marker of small hepatocellular carcinoma. Cancer 94, 175-180.
46. Sottrup-Jensen, L. (1989). Alpha-2 macroglobulins: structure, shape and mechanism of proteinase complex formation. J Biol Chem 264, 11539-11542.
47. Su, F. & Schneider, R. J. (1996). Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitors of rel-related proteins. J Virol 70, 4558-4566.
48. Teicher, B. A. (2001). Malignant cells, directors of the malignant process: role of transforming growth factor-beta. Cancer Metastasis Res 20, 133-143.
49. Tiggelman, A. M., Linthorst, C., Boers, W., Brand, H. S. & Chamuleau, R. A. (1997). Transforming growth factor-β-induced collagen synthesis by human liver myofibroblasts is inhibited by α2-macroglobulin. J Hepatol 26, 1220-1228.
50. Twu, J. S., Rosen, C. A., Haseltine, W. A. & Robinson, W. S. (1989). Identification of a region within the human immunodeficiency virus type 1 long terminal repeat that is essential for transactivation by the hepatitis B virus gene X. J Virol 63, 2857-2860.
51. Ueda, H., Ullrich, S. J., Gangemi, J. D., Kappel, C. A., Ngo, L., Feitelson, M. A. & Jay, G. (1995). Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9, 41-47.
52. Umans, L., Serneels, L., Overbaugh, L., Lorent, K., Van Leuven, F. & Van den Berghe, H. (1995). Targeted inactivation of the mouse α2-macroglobulin gene. J Biol Chem 270, 19778-19785.
53. Wada, I., Kanada, H., Nomura, K., Kato, Y., Machinami, R. & Kitagawa, T. (1999). Failure to detect genetic alteration of the mannose-6-phosphate/insulin-like growth factor 2 receptor. Hepatology 29, 1718-1721.
54. Webb, D. J., Wen, J., Lysiak, J. J., Umans, L., Van Leuver, F. & Gonias, S. L. (1996). Murine α-macroglobulins demonstrate divergent activities as neutralizers of transforming growth factor β and as inducers of nitric oxide synthesis. J Biol Chem 271, 24982-24988.
55. Webb, D. J., Wen, J., Karns, L. R., Kurilla, M. G. & Gonias, S. L. (1998). Localization of binding site for transforming growth factor-β in human α2-macroglobulin to a 20-KDa peptide that also contains the bait region. J Biol Chem 273, 13339-13346.
56. Williams, S. E., Kounnas, M. Z., Argraves, K. M., Argraves, W. S. & Strickland, D. K. (1994). The α2-macroglobulin receptor/low density lipoprotein receptor protein and the receptor-associated protein: an overview. Ann N Y Acad Sci 737, 1-13.
57. Yamada, T., De Souza, A. T., Finkelstein, S. & Jirtle, R. L. (1997). Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A 94, 10351-10355.
58. Yoo, Y. D., Ueda, H., Park, K., Flanders, K. C., Lee, Y. I., Jay, G. & Kim, S. J. (1996). Regulation of transforming growth factor-β1 expression by the hepatitis B virus (HBV) X transactivator. J Clin Invest 97, 388-395.